Zhou H Catalogue en ligne

Détail de l'auteur

Auteur Zhou H

Documents disponibles écrits par cet auteur (47)

trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche

Article

Methods in molecular biology (Clifton, N.J.), 2587. Exon-Skipping for a Pathogenic COL6A1 Variant in Ullrich Congenital Muscular Dystrophy

Aguti S ; Guirguis F ; Bonnemann C ; Muntoni F ; Bolduc V ; Zhou H | United States | 2023

Plus d'information...

Ajouter au panier

En ligne

Article

The Journal of clinical investigation Microvasculopathy in SMA is driven by a reversible autonomous endothelial cell defect

Zhou H ; Zhou H ; Hong Y ; Scoto M ; Thomson A ; Pead E ; MacGillivray T ; Hernandez-Gerez E ; Catapano F ; Meng J ; Zhang Q ; Hunter G ; Shorrock HK ; Ng TK ; Hamida A ; Sanson M ; Baranello G ; Howell K ; Gillingwater TH ; Brogan P ; Thompson DA ; Parson SH ; Muntoni F | United States | 13/09/2022

Plus d'information...

Ajouter au panier

En ligne

Article

Frontiers in neurology, 13. Oral Microbiota Profile in a Group of Anti-AChR Antibody-Positive Myasthenia Gravis Patients

Huang C ; Gao F ; Zhou H ; Zhang L ; Shang D ; Ji Y ; Duan Z | 07/07/2022

Plus d'information...

Ajouter au panier

En ligne

Article

Frontiers in molecular neuroscience, 15. Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities

Lange J ; Lange J ; Zhou H ; McTague A | 27/06/2022

Plus d'information...

Ajouter au panier

En ligne

Article

Annals of clinical and translational neurology Response of plasma microRNAs to nusinersen treatment in patients with SMA

Zaharieva IT ; Scoto M ; Aragon Gawinska K ; Ridout D ; Doreste B ; Servais L ; Muntoni F ; Zhou H | United States | 18/05/2022

Plus d'information...

Ajouter au panier

En ligne

Article

Neurology and therapy Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

Yan C ; Duan RS ; Yang H ; Li HF ; Zou Z ; Zhang H ; Zhou H ; Li XL ; Zhou H ; Jiao L ; Chen J ; Yin J ; Du Q ; Lee M ; Chen Y ; Chen X ; Zhao C | New Zealand | 12/04/2022

Plus d'information...

Ajouter au panier

En ligne

Article

European journal of neurology Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis

Ruan Z ; Guo R ; Zhou H ; Gao F ; Lin Y ; Xu Q ; Yu L ; Wu S ; Lei T ; Zhang M ; Gao Y ; Lu X ; Li H ; Sun C ; Tang B ; Li Z ; Chang T | England | 21/02/2022

Plus d'information...

Ajouter au panier

En ligne

Article

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study

Li H ; Ruan Z ; Gao F ; Zhou H ; Guo R ; Sun C ; Xu Q ; Lu Q ; Zhou Y ; Zhao Z ; Yu L ; Wu S ; Lei T ; Gao T ; Tang Y ; Li C ; Huo F ; Zhu Y ; Sun J ; Tang B ; Zhang M ; Gao Y ; Lu X ; Li Z ; Chang T | United States | 08/10/2021

Correction to: Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: a Multicenter Retrospective Cohort Study Li H et al Neurotherapeutics. 2021 Nov 8. doi: 10.1007/s13311-021-01144-0. Correction for the affiliati[...]

Plus d'information...

Ajouter au panier

En ligne

Article

Stem cell reports Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies

Ortiz Cordero C ; Bincoletto C ; Dhoke NR ; Selvaraj S ; Magli A ; Zhou H ; Kim DH ; Bang AG ; Perlingeiro RCR | United States | 30/09/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Journal of neuroimmunology, 358. Sexual dysfunction in patients with myasthenia gravis

Wang J ; Yan C ; Zhao Z ; Chen H ; Shi Z ; Du Q ; Zhang Y ; Qiu Y ; Lang Y ; Kong L ; Cai L ; Zhou H | Netherlands | 15/09/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Cell reports, 36, 2. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy

Dhoke NR ; Kim H ; Selvaraj S ; Azzag K ; Zhou H ; Oliveira NAJ ; Tungtur S ; Ortiz Cordero C ; Kiley J ; Lu QL ; Bang AG ; Perlingeiro RCR | 13/07/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Proceedings of the national Academy of sciences of the United States of America, 118, 13. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS

Sun L ; Wei N ; Kuhle B ; Blocquel D ; Novick S ; Matuszek Z ; Zhou H ; He W ; Zhang J ; Weber T ; Horvath R ; Latour P ; Pan T ; Schimmel P ; Griffin PR ; Yang XL | 30/03/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Annals of clinical and translational neurology The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy

Spicer C ; Lu CH ; Catapano F ; Scoto M ; Zaharieva I ; Malaspina A ; Morgan JE ; Greensmith L ; Muntoni F ; Zhou H | United States | 08/03/2021

Plus d'information...

Ajouter au panier

En ligne

Article

eLife, 10. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes

Ortiz Cordero C ; Magli A ; Dhoke NR ; Kuebler T ; Selvaraj S ; Oliveira NA ; Zhou H ; Sham YY ; Bang AG ; Perlingeiro RC | 29/01/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Molecular therapy. Nucleic acids, 21. Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD

Aguti S ; Aguti S ; Bolduc V ; Ala P ; Turmaine M ; BÃ nnemann CG ; Muntoni F ; Zhou H | 06/2020

Plus d'information...

Ajouter au panier

En ligne

Article

Journal of cachexia, sarcopenia and muscle Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

Zhou H ; Meng J ; Malerba A ; Catapano F ; Sintusek P ; Jarmin S ; Feng L ; Lu Nguyen N ; Sun L ; Mariot V ; Dumonceaux J ; Morgan JE ; Gissen P ; Dickson G ; Muntoni F | Germany | 02/2020

Plus d'information...

Ajouter au panier

En ligne

Article

Cardiac Phenotype-Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review

Zhou H | 2020

Plus d'information...

Ajouter au panier

Article

Journal of cachexia, sarcopenia and muscle The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al

Zhou H ; Muntoni F | Germany | 2020

Plus d'information...

Ajouter au panier

En ligne

Article

Methods in molecular biology (Clifton, N.J.), 2176. Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy

Aguti S ; Marrosu E ; Muntoni F ; Zhou H | United States | 2020

Plus d'information...

Ajouter au panier

En ligne

Article

JCI insight, 4, 6. A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies

Bolduc V, Auteur ; Foley AR ; Solomon-Degefa H ; Sarathy A ; Donkervoort S ; Hu Y ; Chen GS ; Sizov K ; Nalls M ; Zhou H ; Aguti S ; Cummings BB ; Lek M ; Tukiainen T ; Marshall JL ; Regev O ; Marek-Yagel D ; Sarkozy A ; Butterfield RJ ; Jou C ; Jimenez-Mallebrera C ; Li Y ; Gartioux C ; Mamchaoui K ; Allamand V ; Gualandi F ; Ferlini A ; Hanssen E ; Wilton SD ; Lamande SR ; Macarthur DG ; Wagener R ; Muntoni F ; Bonnemann CG | 21/03/2019

Plus d'information...

Ajouter au panier

En ligne

Article

Expert opinion on biological therapy, 18, 6. The progress of AAV-mediated gene therapy in neuromuscular disorders

Aguti S, Auteur ; Malerba A ; Zhou H | 2018

Plus d'information...

Ajouter au panier

En ligne

Article

Molecular therapy. Nucleic acids, 8. Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy

Marrosu E, Auteur ; Ala P ; Muntoni F ; Zhou H | 2017

Plus d'information...

Ajouter au panier

En ligne

Article

Molecules (Basel, Switzerland), 22, 4. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

Sardone V, Auteur ; Zhou H ; Muntoni F ; Ferlini A ; Falzarano MS | 2017

Plus d'information...

Ajouter au panier

En ligne

Article

Therapeutic advances in neurological disorders, 10, 9. Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Zhou L, Auteur ; Liu W ; Li W ; Li H ; Zhang X ; Shang H ; Bu B ; Deng H ; Fang Q ; Li J ; Zhang H ; Song Z ; Ou C ; Yan C ; Liu T ; Zhou H ; Bao J ; Lu J ; Shi H ; Zhao C | 2017

Plus d'information...

Ajouter au panier

En ligne

Article

Molecular therapy. Nucleic acids, 5, 7. Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy

Catapano F, Auteur ; Zaharieva I ; Scoto M ; Marrosu E ; Morgan J ; Muntoni F ; Zhou H | 2016

Plus d'information...

Ajouter au panier

En ligne

MYOBASE

Newsletters

Bibliographies

Portail documentaire sur les maladies neuromusculaires

Se connecter

Accueil

Sélection de la langue

Adresse

Détail de l'auteur

Auteur Zhou H

Documents disponibles écrits par cet auteur (47)

Methods in molecular biology (Clifton, N.J.), 2587. Exon-Skipping for a Pathogenic COL6A1 Variant in Ullrich Congenital Muscular Dystrophy

The Journal of clinical investigation Microvasculopathy in SMA is driven by a reversible autonomous endothelial cell defect

Frontiers in neurology, 13. Oral Microbiota Profile in a Group of Anti-AChR Antibody-Positive Myasthenia Gravis Patients

Frontiers in molecular neuroscience, 15. Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities

Annals of clinical and translational neurology Response of plasma microRNAs to nusinersen treatment in patients with SMA

Neurology and therapy Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

European journal of neurology Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study

Stem cell reports Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies

Journal of neuroimmunology, 358. Sexual dysfunction in patients with myasthenia gravis

Cell reports, 36, 2. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy

Proceedings of the national Academy of sciences of the United States of America, 118, 13. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS

Annals of clinical and translational neurology The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy

eLife, 10. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes

Molecular therapy. Nucleic acids, 21. Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD

Journal of cachexia, sarcopenia and muscle Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

Cardiac Phenotype-Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review

Journal of cachexia, sarcopenia and muscle The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al

Methods in molecular biology (Clifton, N.J.), 2176. Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy

JCI insight, 4, 6. A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies

Expert opinion on biological therapy, 18, 6. The progress of AAV-mediated gene therapy in neuromuscular disorders

Molecular therapy. Nucleic acids, 8. Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy

Molecules (Basel, Switzerland), 22, 4. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease

Therapeutic advances in neurological disorders, 10, 9. Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Molecular therapy. Nucleic acids, 5, 7. Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy